CW April 2006
Volume 15Issue Number 4 April 2006 ISSN 10593802 Phase II Clinical Trial of A-007 in Cervical Cancer Patients InitiatedA multi-center Phase II clinical trial that will determine the pathological response of A-007 in patients with high-grade cervical intraepithelial neoplasia (CIN) is being initiated by Tigris Pharmaceuticals, Inc.
Go to Previous Page Go to Next Page Source & Additional Reading F. Garcia et al., Medical Director of Obstetrics and Gynecology, University of Arizona. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
